North America is expected to hold the highest market share in the Diabetes Supplement Market.

North America is grabbing one of the largest share in the global diabetes supplement market This can be attributed to the increasing prevalence of prediabetes and obesity and the rising geriatric population. As per the CDC, in the U.S. alone, around 84.1 million people (33.9% of the population)  aged 18 and older suffered from prediabetes in 2015, and nearly 48.3% of the geriatric population suffered from prediabetes conditions. The U.S. is dominating the diabetes supplement market in North America. As per the Council for Responsible Nutrition (CRN), in the U.S., about 60% of the people consume diabetic supplements.

The Asia Pacific is the fastest-growing diabetes supplement market. The region is housing the highest population suffering from diabetes and prediabetes diseases. To attend to the situation, the governments in the region are heavily investing in the healthcare sector to provide better treatment options, which is likely to boost the market growth to some extent. Additionally, the region is backed with the presence of leading contributors, i.e., China and India, where the population of diabetes is increasing at a concerning rate due to the rising prevalence of obesity and sedentary lifestyle. As per the National Urban Diabetes Survey, around 14% of the total population is suffering from diabetes in the region. Moreover, in India, the diabetic supplements market, including protein and herbal supplements, accounts for over 60% of the Indian market. This can be attributed to the increasing prevalence of chronic metabolic diseases and rising awareness regarding the maintenance of health among Indian consumers.

Europe is expected to be a leading region in the global diabetes supplement market on account of the increasing prevalence of prediabetes and diabetes diseases, rising healthcare expenditure, growing consumption of unhealthy food, and rising prevalence of metabolic conditions. As per the British Diabetic Association, in 2017, around 3.1 million people suffered from diabetes. According to the International Diabetes Federation, Europe spent over USD 100 billion on diabetes in 2010, and the expenditure is expected to reach USD 125 billion by 2030